NextGen Jane Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.02M

  • Investors
  • 16

NextGen Jane General Information

Description

Developer of diagnostic tools designed to offer information and data on women's reproductive health. The company's tools use a patented tampon collection technology to transform the diverse molecular signals from the endometrium, cervix, fallopian tubes, and ovaries shed during menstruation into digital diagnoses for in-depth sequencing analysis and disease detection, enabling women to send their menstrual samples and predict reproductive diseases in a hassle-free manner.

Contact Information

Formerly Known As
NextGenJane
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Medical Supplies
Corporate Office
  • 400 29th Street
  • Suite 105
  • Oakland, CA 94609
  • United States
+1 (415) 000-0000

NextGen Jane Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NextGen Jane Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 02-Oct-2023 $7.02M 000.00 Completed Generating Revenue
6. Later Stage VC 09-Jun-2022 00.00 000.00 Completed Generating Revenue
5. Grant 23-Feb-2022 00.000 000.00 Completed Generating Revenue
4. Grant 01-Jan-2020 00000 000.00 Completed Startup
3. Later Stage VC (Series A) 29-Mar-2019 000 000.00 000.00 Completed Startup
2. Seed Round 09-Mar-2016 $2.22M $2.22M 00.000 Completed Startup
1. Accelerator/Incubator 09-Dec-2015 Completed Startup
To view NextGen Jane’s complete valuation and funding history, request access »

NextGen Jane Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
To view NextGen Jane’s complete cap table history, request access »

NextGen Jane Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diagnostic tools designed to offer information and data on women's reproductive health. The company's tools
Other Devices and Supplies
Oakland, CA
10 As of 2024
000.00
0000000000 0 000.00

000000

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000000 00000000
Wijnegem, Belgium
00 As of 0000
00.000
000000&0 00.000

000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
00000000 0000000
Trumbull, CT
0000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NextGen Jane Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novosanis Formerly VC-backed Wijnegem, Belgium 00 00.000 000000&0 00.000
CooperSurgical Corporate Backed or Acquired Trumbull, CT 0000
Genomic Expression Venture Capital-Backed Beverly, MA 00 00.00 00000 00000
Living DNA Corporation Frome, United Kingdom 0
Illumina Formerly VC-backed San Diego, CA 0000 00.000 0000 00.000
You’re viewing 5 of 5 competitors. Get the full list »

NextGen Jane Patents

NextGen Jane Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4267009-A1 Systems and methods for preservation of a cervicovaginal fluid sample Pending 23-Dec-2020 00000000000
US-20240041439-A1 Systems and methods for preservation of a cervicovaginal fluid sample Pending 23-Dec-2020 00000000000
EP-4179117-A1 Fetal trophoblast compositions and methods Pending 07-Jul-2020 00000000000
US-20230257698-A1 Fetal trophoblast compositions and methods Pending 07-Jul-2020 0000000000
AU-2020376052-A1 Methods and systems for menstrualome analysis Pending 01-Nov-2019 C12Q1/6883
To view NextGen Jane’s complete patent history, request access »

NextGen Jane Executive Team (3)

Name Title Board Seat
Ridhi Tariyal Co-Founder, President, Chief Executive Officer & Board Member
Xitong Li Ph.D Chief Technology Officer
Stephen Gire Co-Founder, Chief Scientific Officer, CPO, Chief Product Designer, and Board Member
To view NextGen Jane’s complete executive team members history, request access »

NextGen Jane Board Members (3)

Name Representing Role Since
Adam Sharkawy Ph.D Material Impact Fund Board Member 000 0000
Deborah Kilpatrick Ph.D Material Impact Fund Board Member 000 0000
Ridhi Tariyal NextGen Jane Co-Founder, President, Chief Executive Officer & Board Member 000 0000
To view NextGen Jane’s complete board members history, request access »

NextGen Jane Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NextGen Jane Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Labcorp Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Access Industries Asset Manager Minority 000 0000 000000 0
Anne Morriss Angel (individual) Minority 000 0000 000000 0
David Walt Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

NextGen Jane FAQs

  • When was NextGen Jane founded?

    NextGen Jane was founded in 2014.

  • Who is the founder of NextGen Jane?

    Ridhi Tariyal and Stephen Gire are the founders of NextGen Jane.

  • Where is NextGen Jane headquartered?

    NextGen Jane is headquartered in Oakland, CA.

  • What is the size of NextGen Jane?

    NextGen Jane has 10 total employees.

  • What industry is NextGen Jane in?

    NextGen Jane’s primary industry is Other Devices and Supplies.

  • Is NextGen Jane a private or public company?

    NextGen Jane is a Private company.

  • What is NextGen Jane’s current revenue?

    The current revenue for NextGen Jane is 000000.

  • How much funding has NextGen Jane raised over time?

    NextGen Jane has raised $19.7M.

  • Who are NextGen Jane’s investors?

    Labcorp Venture Fund, U.S. Department of Health and Human Services, Access Industries, Anne Morriss, and David Walt are 5 of 16 investors who have invested in NextGen Jane.

  • Who are NextGen Jane’s competitors?

    Novosanis, CooperSurgical, Genomic Expression, Living DNA, and Illumina are competitors of NextGen Jane.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »